Shandong Pharmaceutical Glass Co.Ltd Stock

Equities

600529

CNE000001BG9

Non-Paper Containers & Packaging

End-of-day quote Shanghai S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
28.71 CNY +0.81% Intraday chart for Shandong Pharmaceutical Glass Co.Ltd -9.69% +12.15%
Sales 2024 * 5.65B 780M Sales 2025 * 6.5B 898M Capitalization 19.05B 2.63B
Net income 2024 * 989M 136M Net income 2025 * 1.17B 161M EV / Sales 2024 * 2.82 x
Net cash position 2024 * 3.1B 427M Net cash position 2025 * 3.69B 509M EV / Sales 2025 * 2.36 x
P/E ratio 2024 *
19.3 x
P/E ratio 2025 *
16.3 x
Employees -
Yield 2024 *
1.65%
Yield 2025 *
1.93%
Free-Float 78.59%
More Fundamentals * Assessed data
Dynamic Chart
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd. CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shandong Pharmaceutical Glass Co., Ltd(SHSE:600529) added to Shanghai Stock Exchange Health Care Sector Index CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.8664947 billion in funding CI
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 day+0.81%
1 week-9.69%
Current month-0.59%
1 month+0.42%
3 months+13.70%
6 months+7.65%
Current year+12.15%
More quotes
1 week
27.42
Extreme 27.42
32.26
1 month
27.42
Extreme 27.42
32.33
Current year
21.61
Extreme 21.61
32.33
1 year
21.61
Extreme 21.61
32.33
3 years
18.63
Extreme 18.63
45.45
5 years
18.01
Extreme 18.0143
76.85
10 years
5.28
Extreme 5.2806
76.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 13-05-10
Director of Finance/CFO 50 13-05-10
Chairman 69 10-04-19
Members of the board TitleAgeSince
Chairman 69 10-04-19
Corporate Secretary 57 10-04-19
Chief Executive Officer 54 13-05-10
More insiders
Date Price Change Volume
24-04-25 28.71 +0.81% 11,781,590
24-04-24 28.48 +2.26% 22,090,320
24-04-23 27.85 -9.99% 26,431,240
24-04-22 30.94 -2.27% 11,819,460
24-04-19 31.66 -0.41% 5,947,418

End-of-day quote Shanghai S.E., April 24, 2024

More quotes
SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
28.71 CNY
Average target price
34.95 CNY
Spread / Average Target
+21.74%
Consensus
  1. Stock Market
  2. Equities
  3. 600529 Stock